Journal article
Musashi-2 (MSI2) supports TGF-beta signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasis
Proceedings of the National Academy of Sciences - PNAS, v 113(25), pp 6955-6960
21 Jun 2016
PMID: 27274057
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Non-small cell lung cancer (NSCLC) has a 5-y survival rate of similar to 16%, with most deaths associated with uncontrolled metastasis. We screened for stem cell identity-related genes preferentially expressed in a panel of cell lines with high versus low metastatic potential, derived from NSCLC tumors of Kras(LA1/+);P53(R172H Delta G/+) (KP) mice. The Musashi-2 (MSI2) protein, a regulator of mRNA translation, was consistently elevated in metastasis-competent cell lines. MSI2 was overexpressed in 123 human NSCLC tumor specimens versus normal lung, whereas higher expression was associated with disease progression in an independent set of matched normal/primary tumor/lymph node specimens. Depletion of MSI2 in multiple independent metastatic murine and human NSCLC cell lines reduced invasion and metastatic potential, independent of an effect on proliferation. MSI2 depletion significantly induced expression of proteins associated with epithelial identity, including tight junction proteins [claudin 3 (CLDN3), claudin 5 (CLDN5), and claudin 7 (CLDN7)] and down-regulated direct translational targets associated with epithelial-mesenchymal transition, including the TGF-beta receptor 1 (TGF beta R1), the small mothers against decapentaplegic homolog 3 (SMAD3), and the zinc finger proteins SNAI1 (SNAIL) and SNAI2 (SLUG). Overexpression of TGF beta RI reversed the loss of invasion associated with MSI2 depletion, whereas overexpression of CLDN7 inhibited MSI2-dependent invasion. Unexpectedly, MSI2 depletion reduced E-cadherin expression, reflecting a mixed epithelial-mesenchymal phenotype. Based on this work, we propose that MSI2 provides essential support for TGF beta R1/SMAD3 signaling and contributes to invasive adenocarcinoma of the lung and may serve as a predictive biomarker of NSCLC aggressiveness.
Metrics
Details
- Title
- Musashi-2 (MSI2) supports TGF-beta signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasis
- Creators
- Alexander E. Kudinov - Fox Chase Cancer CenterAlexander Deneka - Fox Chase Cancer CenterAnna S. Nikonova - Fox Chase Cancer CenterTim N. Beck - Fox Chase Cancer CenterYoung-Ho Ahn - The University of Texas MD Anderson Cancer CenterXin Liu - The University of Texas MD Anderson Cancer CenterCathleen F. Martinez - University of New MexicoFred A. Schultz - University of New MexicoSamuel Reynolds - University of New MexicoDong-Hua Yang - Fox Chase Cancer CenterKathy Q. Cai - Fox Chase Cancer CenterKhaled M. Yaghmour - Fox Chase Cancer CenterKarmel A. Baker - Fox Chase Cancer CenterBrian L. Egleston - Fox Chase Cancer CenterEmmanuelle Nicolas - Fox Chase Cancer CenterAdaeze Chikwem - Fox Chase Cancer CenterGregory Andrianov - Kazan Federal UniversityShelly Singh - Fox Chase Cancer CenterHossein Borghaei - Fox Chase Cancer CenterIlya G. Serebriiskii - Kazan Federal UniversityDon L. Gibbons - The University of Texas MD Anderson Cancer CenterJonathan M. Kurie - College Station Medical CenterErica A. Golemis - Drexel UniversityYanis Boumber - Fox Chase Cancer Center
- Publication Details
- Proceedings of the National Academy of Sciences - PNAS, v 113(25), pp 6955-6960
- Publisher
- Natl Acad Sciences
- Number of pages
- 6
- Grant note
- LC140074 / DOD; United States Department of Defense Conquer Cancer Foundation (ASCO) Young Investigator Award UNM Core Funding NRF 2010-0027945 / National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning AHEPA Foundation K08 CA151651; R01 CA157450 / NIH; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA 15-15-20032 / Russian Science Foundation; Russian Science Foundation (RSF) MD Anderson Physician-Scientist Award Lung Cancer Research Foundation (LCRF) American Cancer Society IRG Pilot Grant F30CA180607 / NATIONAL CANCER INSTITUTE; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI) P30 CA006927; CA016672; CA181287; R21CA191425 / NCI; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI) F30 CA180607 / Ruth L. Kirschstein NRSA F30 fellowship from NIH
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Biochemistry and Molecular Biology
- Web of Science ID
- WOS:000378272400050
- Scopus ID
- 2-s2.0-84975698737
- Other Identifier
- 991019319080704721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- International collaboration
- Web of Science research areas
- Oncology